Transverse pin femoral fixation of bone-patella tendon-bone (BPTB) in ACL reconstruction has been widely applied during the last decades. Aim of our study is to confront two different system of transverse femoral fixation for BPTB graft: Transfix BTB (Arthrex) and BioTransfix T3 (Arthrex). The main differences between these two system are the diameter (3.0 mm Transfix BTB and 3.5 mm BioTransfix T3), and section (Transfix BTB is cannulated). Surgical technique adopts the same transverse vectorial guide but different guide sleeves.

30 fresh-frozen porcine knees (mean age 2.2 years) were assigned to the two groups randomisedly. the patellar bone block and tendon were harvested using the same size in all specimens (10mm × 25 mm, 10 mm). Zwick-Roell z010 tension/compression device with bone clamps, was used for the study:

Cyclic test (1000 cycles, 0.5 Hz, 50–250 N/cycle, 100 cycles of preload)

Final pull-out test (1 mm/s)

Failure analysis

CT scan and densitometry

Any implant didn't fail during cyclic test. The elongation average was 1.85±0.63 for Transfix BTB and 1.69±0.87 for BioTransfix T3. Pull-out test showed very similar values in terms of Ultimate Strength Failure (USF), Stiffness at USF, and Stiffness:

The failure mode was bone plug fracture (12 for Transfix BTB and 13 for BioTransfix T3) and tendon failure (3 for Transfix BTB and 2 for BioTransfix T3).

The post-test CT scan showed any failure of the fixation devices and the correct position inside the femoral half-tunnel.

The mean bone density of porcine femora was comparable to young human femora (1.12±0.31 BMD)

Both systems showed a similar behaviour in terms of USF, Stiffness, Cyclic load, method of failure and other biomechanical parameters. The reproducibility of surgical technique, the mechanical strength and endurance of the systems suggest two valid options for ACL reconstruction with BPTB even if in-vivo studies are necessary to confirm the animal ex-vivo biomechanical data.